Wu, Qianhui
Dudley, Matthew Z.
Chen, Xinghui
Bai, Xufang
Dong, Kaige
Zhuang, Tingyu
Salmon, Daniel
Yu, Hongjie
Funding for this research was provided by:
China National Funds for Distinguished Young Scientists (No. 81525023)
Key Emergency Project of Shanghai Science and Technology Committee (No 20411950100)
Article History
Received: 22 March 2021
Accepted: 12 July 2021
First Online: 28 July 2021
Declarations
:
: Not applicable.
: Not applicable.
: H.Y. has received research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company, and Shanghai Roche Pharmaceutical Company. M.D. has received research support from Walgreen Company and Merck. D.S. has received consulting or grant funding from Merck and Janssen. None of those research funding is related to development of COVID-19 vaccines. All other authors report no competing interests.